Collectively, this suggests that Chr9p21 risk alleles may alter lysoPL/lysoPA in humans via ANRIL regulation, providing novel insights into the biology of this important cause of CHD. This evidence concerns the gene CDKN2B-AS1 and coronary artery disorder.